Cargando…
Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease
Background: Blood levels of immune markers have been proposed to discriminate patients with Parkinson's disease (PD) from controls. However, differences between clinical PD subgroups regarding these markers still need to be identified. Objective: To investigate whether clinical phenotypes can b...
Autores principales: | Yilmaz, Rezzak, Strafella, Antonio P., Bernard, Alice, Schulte, Claudia, van den Heuvel, Lieneke, Schneiderhan-Marra, Nicole, Knorpp, Thomas, Joos, Thomas O., Leypoldt, Frank, Geritz, Johanna, Hansen, Clint, Heinzel, Sebastian, Apel, Anja, Gasser, Thomas, Lang, Anthony E., Berg, Daniela, Maetzler, Walter, Marras, Connie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308160/ https://www.ncbi.nlm.nih.gov/pubmed/30622507 http://dx.doi.org/10.3389/fneur.2018.01123 |
Ejemplares similares
-
Inflammatory profile in LRRK2-associated prodromal and clinical PD
por: Brockmann, Kathrin, et al.
Publicado: (2016) -
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
por: Lerche, Stefanie, et al.
Publicado: (2023) -
Comparison of Bead-Based Fluorescence Versus Planar Electrochemiluminescence Multiplex Immunoassays for Measuring Cytokines in Human Plasma
por: Günther, Anna, et al.
Publicado: (2020) -
Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors
por: Bernhard, Felix P., et al.
Publicado: (2016) -
Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls
por: Maetzler, Walter, et al.
Publicado: (2014)